All In Biotech

Drug Trial Radar · NCT03081949

Peripartum Cardiomyopathy in Nigeria Registry

Peripartum Cardiomyopathy in Nigeria (PEACE) A Registry to Study the Demographics, Social and Clinical Characteristics, Pathophysiology and Outcomes of Peripartum Cardiomyopathy in Nigeria

Last checked: Nov 20, 2026Latest source record: Jan 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Jun 12, 2017

Primary completion

Jun 30, 2019

Study completion Dec 31, 2019

Sponsor

Lead sponsor
Aminu Kano Teaching HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Nigerian Cardiac Society
First posted
Mar 17, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality, and Nigeria probably has the highest burden of the disease in the world. Unfortunately, much about the disease including its aetiology, epidemiology and treatment is not yet well described. This will be a prospective, national, multicenter cohort study, conducted in centres in Nigeria. It is expected that approximately 500 patients with PPCM and 500 apparently healthy pregnant women will be recruited over a 6-month period with follow-up at 3-monthly intervals for 18 months.

Conditions

  • Peripartum Cardiomyopathy

Interventions

  • Oral Sodium Selenite 200 µg/day for 3 monthsDrug

    PPCM patients with selenium deficiency, who have not achieved LV reverse remodelling (LVRR) (LV end-diastolic dimension indexed to body surface area (LVEDDi) ≤33.0 mm/m2) at 6 months after diagnosis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prevalence of peripartum cardiomyopathy (PPCM) in NigeriaTime frame: Over 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Aminu Kano Teaching Hospital

    Kano, Nigeria

  • Aminu Kano Teaching Hospital

    Kano, Nigeria

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.